Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Nireeksha Shetty
 + 3163 word(s) 3163 2021-05-19 06:31:06 |
2 update layout and reference
Rita Xu
-1 word(s) 3162 2021-05-19 07:41:56 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Shetty, N. Pulp Inflammation and Regeneration. Encyclopedia. Available online: https://encyclopedia.pub/entry/9821 (accessed on 19 July 2024).
Shetty N. Pulp Inflammation and Regeneration. Encyclopedia. Available at: https://encyclopedia.pub/entry/9821. Accessed July 19, 2024.
Shetty, Nireeksha. "Pulp Inflammation and Regeneration" Encyclopedia, https://encyclopedia.pub/entry/9821 (accessed July 19, 2024).
Shetty, N. (2021, May 19). Pulp Inflammation and Regeneration. In Encyclopedia. https://encyclopedia.pub/entry/9821
Shetty, Nireeksha. "Pulp Inflammation and Regeneration." Encyclopedia. Web. 19 May, 2021.
Pulp Inflammation and Regeneration
Edit
This entry is adapted from the peer-reviewed paper 10.3390/cimb43010010

The role of inflammatory mediators in dental pulp is unique. The local environment of pulp responds to any changes in the physiology that are highly fundamental, like odontoblast cell differentiation and other secretory activity. 

cathelicidins dental pulp inflammation dental caries innate immunity

1. Introduction

The dental pulp undergoes various stages of repair and regeneration throughout its functioning as a result of microbial activity and other insults. The repair and regeneration process mainly occurs due to molecular signaling pathways, inflammatory cascades, and immunomodulatory effects [1]. The local environment of the pulp responds to any changes in physiology that are highly fundamental, such as odontoblast cell differentiation and other secretory activity [2]. Presenting host cell damage and maintaining a sterile pulpal environment is one of the aims of pulpal health. The external factors that affect the pulpal environment include dental caries, physical, mechanical, and chemical irritation, and microbial infection [3].

The histology of reversibly injured dental pulp shows an absence of bacteria and localized coagulation necrosis, while in inflamed pulp, it exhibits the infiltration of inflammatory cells such as neutrophils, suggesting chemotaxis [2][4]. These inflammatory cells release lysosomal enzymes that cause tissue destruction, leading to permanent, irreversible damage, or necrosis [5], requiring endodontic treatment with/without placement of intracanal medicaments to achieve complete disinfection and the prevention of postendodontic pain [6][7]. Various signaling events in the pulp stimulate various mediators, which play vital roles in the progression of inflammation or result in abrupt regression of the inflammatory process [8]. T-lymphocytes are essential residents of dental pulp. Initial accumulation of CD3+ T-lymphocytes, plasma cells, and neutrophils around pulpal dendritic cells are usually seen [9]. The interaction between the dendritic cells and T-lymphocytes results in the mobilization and activation of different cells, thereby causing immuno-pathological events. The increased influx of plasma cells, the production of immunoglobulin, and the perivascular presence of dendritic cells leads to immune response [9]. This increased patrolling by memory T-lymphocytes and macrophage-derived cytokines IL-1, IL-6, and TNF-α, as well as upregulation of the adherence molecules intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule (VCAM-1), and endothelium-leukocyte adhesion molecule (ELAM-1) on the surfaces of endothelial cells, explains the inflammatory process in the pulp [9].

Cathelicidins are antimicrobial peptides naturally occurring in saliva [9][10], gingival crevicular fluid (GCF) [11], and blood. They possess antimicrobial and antiviral capabilities, which can be useful for formulating drugs. The oral cavity is an exceptional environment for microorganisms to quickly gain access. The widespread distribution of cathelicidins results in action against microorganisms [12]. Antimicrobial peptides can include anionic peptides, which are small and rich in glutamic acids and aspartic acid, although LL-37 from humans are linear cationic α-helical peptides [13][14]. Anionic and cationic peptides containing one or more disulphide bonds, like protegrin from pigs, tachypleins from horse grabs, and α-β-defensins from humans, are similar to antimicrobial peptides like lactoferrin [15]. The LL-37 antimicrobial peptide is regulated by the CAMP gene. A known inducer of CAMP gene expression is 1,25 dihydroxyvitamin-D through Vitamin-D receptor binding to the Vitamin-D responsive element at 500 bp upstream of the CAMP gene promoter [16]. The first experiment to prove LL-37 peptide expression upregulation, to fight against bacterial infection was carried out using a cystic fibrosis xenograft model, where a planned overexpression of LL-37 using an adenovirus vector was performed [17]. A promising candidate for inducing LL-37 is 1,25-dihydroxyvitamin D3 through Toll-like receptor via the TLR2/1- Vitamin D Cathelicidins (LL-37) pathway (see Figure 1).

Cimb 43 00010 g001 550

Figure 1. Representation of the TLR2/1–Vitamin D cathelicidins (LL-37) pathway.

In endodontics, these cathelicidins are addressed based on their capacity to heal wounds, their immunomodulatory potential, and their ability to stimulate cytokine production and recruit immune-inflammatory response in pulp and periapex by regulating reparative dentin formation through the stimulation of odontoblasts [18]. These peptides are highly potent therapeutic agents against viral, bacterial, and fungal pathogens. These synthetic peptides, which possess unique properties, are also referred to as peptidomimetics, and evolved from contemporary research endeavors [19]. A synthetic peptide like VS2, VSL2, has also proven to be bactericidal against endodontic pathogens and decreases bacterial load to a depth of 400 µm [20].

Antimicrobial peptide LL-37 and its potential role in innate immunity, dental caries pathogenesis, periodontal health, and other oral inflammatory conditions have been evaluated, and a number of factors with relation to clinical evidence are available. It is essential to focus on their oral health potential, and specifically on dental pulp inflammation [21][22].

2. Structure and Function of LL-37

Understanding the structure and function of these peptides is essential and well established. They are released biochemically in two different prokaryotes; they are ribosomally synthesized and, in particular, within mammalian leukocytes; the granules hold large amounts of antimicrobial peptides precursor molecules [23]. Cathelicidins are a structurally and functionally distinct protein class as part of innate immunity in mammals.

These peptides were first isolated from bovine neutrophils called Bac5, further cloning cDNA to reach the gene [24]. The hallmark of these peptide families is the presence of highly preserved cathelicidin domain. It was termed ‘alarmins,’ referring to its capacity to modulate inflammation, limiting damage to host cells, improving wound healing, angiogenesis, and eliminating abnormal cells [25]. LL37/hcap18 is the only known cathelicidins referred to as ‘Pleotrophic,’ ‘Multifaceted,’ ‘Multifunctional,’ and ‘factotum’ [26].

The structure has a highly conserved N-terminal domain with 100 amino acid residues. It has N-terminal and an antimicrobial domain. It is an 18 kDa protein, the primary product after translation is called Pre-protein, which is a prelude to cathelicidin holo-protein [27] (Figure 2). The single cleaved protein further targets the cathelicidins to the storage granules or the cell exterior. This form is called inactive or storage form. It further cleaves into the cathelin domain and participates in host activities [28] (Figure 2).

Cimb 43 00010 g002 550

Figure 2. Pictorial depiction of LL-37 structure. (a) N-terminal fragment of LL-37, (b) Cathelin like the domain of human cathelicidins, (c) C-terminal fragment of LL-37.

LL-37 belongs to α-helical A.M’P.’s. They are present in different cells, tissues, and body fluids at varying concentrations, mainly saliva [29], wound fluids [30], gingiva [31], leukocytes [32], and squamous epithelial cells [33]; its presence is also enhanced within intracellular fluids in case of minor inflammation and infection. The action of these antimicrobial peptides is present against Streptococcus Mutans group A, B, C, Staphylococcus Aureus [34], E.faecalis [35], Lactobacillus acidophilus [36], pseudomonas aeruginosa, Aggregatibacter Actinomycetumcomitans, Candida Albicans, spirochetes, and yeasts [26].

Cathelicidins show a high-affinity binding property to lipopolysaccharides. It has the virulence to neutralize L.P.S. [27]. LL-37 contributes to angiogenesis and wound healing along with promoting epithelial cell proliferation and transactivation of epidermal growth factors [28]. Biofilm inhibition is also achieved in many ways by preventing attachment of bacterial cells, improvising quorum sensing system, and down-regulation of gene promoting biofilm formation [29]. Some of the significant activities of cathelicidins on host cells are forming transient pores on the cellular membranes, causing bacterial cell dissociation, leakage of components, transactivation of receptors, interacting with binding sites, neutralization of microbial lipopolysaccharides released from damaged host cells, and initiating pro-inflammatory response [30]. Hence, cathelicidins are clearly a part of innate immunity, whereby they decrease microbial adhesion, and are also a potential part of dental caries pathogenesis.

3. Antimicrobial Peptide Cathelicidins and Caries

The primary etiological cause of dental caries is predominantly the presence of streptococcus mutans [32]. The components of unstimulated and stimulated saliva that flow or bathes the tooth surface inhibits the adhesion, colonization and binding of these bacteria [33]. These peptides are bactericidal and overcome bacterial resistance mechanisms [34]. Various A.M’P.’s detected in saliva, namely H.N.P. 1-3, LL-37, defensins, and their expression dictates the growth, proliferation, and survival of different microbial species [35]. Antimicrobial peptides in saliva provide immediate action against destructive microbial species, thereby providing optimal protection against caries progression, prevents overgrowth of microorganisms, and simultaneously maintaining a stable ecology system [36].

The source for salivary antimicrobial peptide LL-37 is salivary gland and ductal cells [37]. The relationship of dental caries and LL-37 peptide has been studied in middle school children, which showed significantly higher levels of LL-37 in the no caries group. The study concluded that the expression of these peptides is associated with caries prevalence [38]. In the estimation of LL-37 in unstimulated whole saliva among children of the age group 2-18 years old, the analysis of LL-37 was found to be low in children with high caries activity compared to children with low and moderate caries activity, suggesting that LL-37 is a vital protector molecule of immunity in the oral cavity [21][22]. A study conducted to evaluate the effect of synthetic peptides β-defensins hBD2,hBD3, and LL-37(Cap18) on oral bacteria, namely A.A.comitans, P.gingivalis, F.nucleatum, S.Mutans, S.Sanguis, S.Mitis, and L.casei showed LL-37 and β-defensins have versatile antibacterial activity against oral bacteria [23]. Antimicrobial peptides play a potential role in pulp protection by odontoblastic stimulation, innate immunity, and reparative dentin formation.

4. Dental Pulp, Innate Immunity and Cathelicidins

The pathogen recognition receptors (P.R.R.) functions as a part of innate immunity functioning in the dental pulp. The family of P.R.R. includes C-type lectin receptors, Toll-like receptors, nucleotide-binding oligomerization domain-like receptors, and AIM2 like receptors that cause immunomodulation [39]. Studies also assess the role of specialized immune cells like cytokines, IL-8, which up-regulates and recruits neutrophils to the inflammation site [40]. This suggests a balance between the inflammatory and repair process in the pulp. IL-6, TNF -α, distribution of human telomerase-derived peptide, and downregulation of L.P.S. induced inflammatory cascades also contribute to this process [1]. The immunocompetent cells located in the periphery of the pulp, namely the odontoblasts, encounter a vast microbial array and have an immense capacity of orchestrating inflammatory response. Odontoblasts have a significant role to play in innate immunity and environmental sensing [4]. These molecular mediators are locally produced and initiate various cellular events that facilitate upregulation and downregulation of specific peptides, creating a specialized environment in pulpal low compliance space [4].

Odontoblasts play a significant role due to reasons like (a) the odontoblastic process that extend into the dentinal tubules making them the first cell to recognize and encounter microorganisms and their bacterial products by penetrating through enamel and dentin [41]; (b) they present antimicrobial peptide [42]; (c) these odontoblast form pseudo epithelial layers that are partially impermeable barrier [43]; (d) they are closely associated with dendritic cells, lymphocytes and thereby respond to any injury to dentin through caries/mechanical/chemical injury [44]; and (e) in response to lipopolysaccharides, they produce IL-8 and stimulate neutrophils chemotaxis to the area of inflammation, all of which suggest a substantial role in immune defense [45]. The Toll-like receptors (T.L.R.) are the primary class of microbial recognition receptors. Activation of T.L.R. regulates the production of antimicrobial peptides, chemokines, cytokines, leukocytes regulation, T cell function, basically providing a bridge between innate and adaptive immunity [46]. The odontoblasts differentially recognize and respond to Gram-negative and Gram-positive bacteria through T.L.R. 2 and T.L.R. 4 utilization and expression [47]. This is further justified by a study that showed that T.L.R. 2 and T.L.R. 4 are prominently distributed at the odontoblast cell body interface and the dentin layer. These validations suggest the efficiency of odontoblasts to attract neutrophils, antimicrobial peptides, and pro-inflammatory cytokines [48]. Pulpal diseases are caused by various bacteria that reside in a low compliance environment within the pulp, creating inflammation and infiltration of mediators like neutrophils, immune cells, and molecules expressed in the cascade of inflammation that serves as biomarkers [49]. The presence of other regulatory inflammatory molecules may also affect the inflammatory response. The identification of biomarkers typically plays an essential part in understanding stages of pulpal inflammation [50].

Pulp tissues were studied by RT-PCR, multiplex assay, microarray, Western blot, radioimmunoassay, immuno-histochemistry, Enzyme-linked-immunosorbent-assay (ELISA), zymography, and flow cytometry [23]. A total of 64 biological markers showed a statistically significant difference between inflamed and healthy pulp [4]. This showed an active presence of antimicrobial peptides in pulp tissue by the RT-PCR technique method, targeting mRNA, which functions as part of the innate and adaptive immune system [18]. To detect the expression of LL-37 in a dental pulp diagnosed with symptomatic irreversible pulpitis and apical periodontitis, it was compared with healthy pulp [51]. In the tooth diagnosed for symptomatic irreversible pulpitis with apical periodontitis, pulp chamber deroofing was done, and pulpal blood samples were collected with paper points and further analyzed for LL-37 levels with ELISA [51]. The mean value of LL-37 in normal pulp was 0.2 ± 0.6 ng/mL and in symptomatic irreversible pulpitis showed 1.5 ± 1.2 ng/mL, which clearly showed high levels of LL-37 in infected dental pulp [51].

Further, it was hypothesized that the expression of LL-37 is due to neutrophil infiltration and its expression in inflamed pulp tissue [18]. Thus, LL-37 is currently discussed in endodontic literature based on its ability to promote human pulp cell migration, resulting in the regeneration of the pulpal dentin complex and dentinal bridge formation. Hence, the potential role of LL-37 can probably be utilized for healing inflamed pulp [52].

To assess the role of odontoblasts in innate immunity by the production of LL-37, an odontoblast-like cell line was obtained from mouse pulp tissue, which structurally and functionally displayed odontoblasts. The effect of bacterial endotoxins L.P.S. from Gram-negative bacteria and L.T.A. from Gram-positive bacteria on the MDPC-23 cell line was studied by assessing IL-6, MMP-8, and LL-37(CRAMP) expression. The odontoblasts possess immune-like cell properties and modulate the innate immunity system. The expression of LL-37 by odontoblasts was associated with reparative dentin formation and innate immunity system via these mechanisms [53].

The antimicrobial peptide LL-37 is present in different cells, tissues, and body fluids, in mature neutrophils and specific granules as pro-proteins bound to plasma lipoproteins which are an important reservoir for LL-37. The up-regulation of these peptides suggests their role in the immune system to battle against inflammatory conditions. Various bacterial products stimulate the production of antimicrobial peptides expression; the expressed peptides perform a diverse role in hampering/slowing down the inflammatory process/disease process [54][55]. Koczulla and co-workers conducted a study to emphasize the role of LL-37 in the neovascularization of the rabbit model [55]. Any wound healing scenario, vascularization, or formation of new blood vessels were essential factors observed in the study. The mediators of inflammation stimulate the formation of new capillaries and enrichment of already persisting vessels [56]. Angiogenic potential of LL-37 peptide was evaluated in a study where human umbilical cord endothelial cells were coated on dishes at different concentrations of LL-37, which was used as a stimulant. The follow-up was done for 18hr. ELISA estimated the VEGF levels in the containers. The study concluded that peptide LL-37 induced angiogenesis due to its direct activity on endothelial cells [55].

The effective induction of angiogenesis may be a significant factor in healing ulcers, wounds, and any inflammatory condition [30]. In vivo application of LL-37 showed vessel growth in physiological and pathological angiogenesis models. A G-protein coupled receptor FPRL1 mediates this cellular response on biding to peptide LL-37 [57]. The pathways that elicit endothelial activation are PLC-γ/PKC/NF-κB, the Erk-1 and -2 MAPK, and the PI3K/Akt factors. LL-37 always attracts neutrophils and monocytes in vivo to the target site [58]. These cells contain various amounts of angiogenic mediators [54]. The pathway is initiated by densely present cells in areas of inflammation or wound sites due to increased expression of LL-37. Thus, the presence of the peptide analogues activates vascular endothelial growth factor [59].

The above mechanism justifies that LL-37 can be an effective candidate for stimulating angiogenesis in pulp [60][61]. LL-37 peptides are considered unstable and easily dissociated by bacteria and host proteases in vivo. The LL-37 with heparin as a complex exerts a bactericidal effect on various oral microbes. Once in contact with the microorganism, LL-37 dissociates and performs relevant actions accordingly [56]. In dental pulp, the heparin LL-37 complex permeates dental pulpal tissue when applied as a pulp capping agent. This complex causes the destruction of the bacterial cell membrane as proposed by carpet, barrel stave, and toroidal models [57]. The regulatory effect on angiogenesis, vascular endothelial growth factor expression in the hDPC’s, immune responses, cellular migration, and bone regeneration can be enhanced by the high dose of LL-37 in cytoplasm without any membrane lytic action that may promote pulp tissue repair [51].

Morbus Kotsmann is a syndrome exhibiting congenital neutropenia. Neutrophils store various potential microbicidal effectors, namely LL-37, α-defensins, and H.N.P. 1-3 [53]. These individuals are treated with granulocytes colony-stimulating factor (G-CSF), which improves the neutrophil count and quality of patients’ lives. Furthermore, even in instances when the neutrophils were in an average amount, infection persisted in these patients, postulating that neutrophils were deficient in antimicrobial peptide, LL-37. The individuals who suffered from Kotsmann Syndrome have poor periodontal health and chronic periodontal disease. The study strongly suggested that the LL-37 has an in vivo role in bacterial infections [58].

The LL-37 peptides stimulate the migration of UDMSC’s (Undifferentiated mesenchymal cells) in pulpal inflammation, bone repair, and reparative dentin formation. Efforts were made to elaborate on the effect of LL-37 on cell viability, which suggests a favorable proliferation of cell lines [59]. Ten µg/mL of LL-37 stimulates dentin sialoprotein and dentin phosphoprotein in dentin mineralization [60]. Therefore, the role of antimicrobial peptides in odontoblast differentiation further corroborates its role as a significant dentinogenesis marker in favorable conditions, which is further validated in this study [60]. However, the study suggests conducting further research in understanding the complete process of odontoblastic differentiation and dentin deposition, which can shed light on pulpal differentiation [18]. Cathelicidins serve as potent mineralization agents. The peptides on the tooth surface prevent demineralization of enamel by acids produced through colonized bacteria [51]. The role of antimicrobial peptides in stimulating odontoblast’s for dentin deposition and preventing bacterial biofilm formation makes these peptides a new tool in the array of synthetic peptides to promote dentin formation and prevent the occurrence of dental caries and periodontal destruction. This potential of LL-37 peptide can be utilized as a pulp capping agent, where this synthetic peptide acts as a precursor for odontoblastic cell differentiation and dentin bridge formation [51] (Figure 3).

Cimb 43 00010 g003 550

Figure 3. Pictorial representation of LL-37 in electrospun fiber membrane as a potential pulp capping agent.

The studies selected showed few drawbacks, but offer a potential area for scope in justifying LL-37 role in decreasing bacterial count, stimulating odontoblastic differentiation, and as a therapeutic agent for pulpal protection [57][59][60]. The role of LL-37 synthetic peptide in inhibition of various resident bacteria in the oral cavity showed scope for understanding, if there is selective inhibition that takes place when treated with LL-37 peptide [55][61]. A study evaluating levels of LL-37 in middle-aged children showed varying levels of beta-defensins (Cathelicidins), whereas alpha-defensins could be used as caries risk assessment factor. The study further provides scope for understanding if the expression of LL-37 can be altered by external stimulation [21][22]. The migration of stem cells of the apical papilla with various concentrations of synthetic peptides showed its efficiency to stimulate, but in vivo studies could help in better understanding the effect of these peptides on apical lesions and proliferation of pulpal cells. The studies selected evaluated LL-37 expression in the inflamed and normal pulp, but were done with smaller sample size. To prevent bias, studies can be done using a larger sample size to evaluate levels of LL-37 expression, and the rate of inflammation required for expression of LL-37 also needs to be evaluated.

References

  1. Schmalz, G.; Smith, A.J. Pulp development, repair, and regeneration: Challenges of the transition from traditional dentistry to biologically based therapies. J. Endod. 2014, 40, S2–S5.
  2. Shabbir, J.; Farooq, I.; Ali, S.; Mohammed, F.; Bugshan, A.; Khurram, S.A.; Khan, E. Dental Pulp. Illus. Guide Oral Histol. 2021, 69–79.
  3. Park, S.H.; Ye, L.; Love, R.M.; Farges, J.C.; Yumoto, H. Inflammation of the Dental Pulp. Mediat. Inflamm. 2015, 2015, 980196.
  4. Cooper, P.R.; Smith, A.J. Molecular mediators of pulp inflammation and regeneration. Endod. Top. 2013, 28, 90–105.
  5. Zehra, T.; Qazi, F.; Abidi, Y.A.; Ahmed, S.; Khalili, S.; Saifee, J. Agreement between Two Commonly Used Pulp Tests in Determining Pulp Vitality. Pakistan J. Med. Dent. 2020, 9, 26–31.
  6. Shabbir, J.; Khurshid, Z.; Qazi, F.; Sarwar, H.; Afaq, H.; Salman, S.; Adanir, N. Effect of Different Host-Related Factors on Postoperative Endodontic Pain in Necrotic Teeth Dressed with Interappointment Intracanal Medicaments: A Multicomparison Study. Eur. J. Dent. 2021, 15, 152–157.
  7. Shabbir, J.; Qazi, F.; Farooqui, W.; Ahmed, S.; Zehra, T.; Khurshid, Z. Effect of Chinese Propolis as an Intracanal Medicament on Post-Operative Endodontic Pain: A Double-Blind Randomized Controlled Trial. Int. J. Environ. Res. Public Health 2020, 17, 445.
  8. Paris, S.; Wolgin, M.; Kielbassa, A.M.; Pries, A.; Zakrzewicz, A. Gene Expression of Human Beta-defensins in Healthy and Inflamed Human Dental Pulps. J. Endod. 2009, 35, 520–523.
  9. Khurshid, Z.; Warsi, I.; Moin, S.F.; Slowey, P.D.; Latif, M.; Zohaib, S.; Zafar, M.S. Biochemical analysis of oral fluids for disease detection. In Advances in Clinical Chemistry; Academic Press: Cambridge, MA, USA, 2021; Volume 100, pp. 205–253. ISBN 9780128239223.
  10. Khurshid, Z.; Moin, S.F.; Khan, R.S.; Agwan, M.A.S.; Alwadaani, A.H.; Zafar, M.S. Human salivary protein extraction from RNAPro·SALTM, Pure·SALTM, and passive drooling method. Eur. J. Dent. 2017, 11, 385–389.
  11. Fatima, T.; Khurshid, Z.; Rehman, A.; Imran, E.; Srivastava, K.C.; Shrivastava, D. Gingival Crevicular Fluid (GCF): A Diagnostic Tool for the Detection of Periodontal Health and Diseases. Molecules 2021, 26, 1208.
  12. Hancock, R.E.W.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551–1557.
  13. Khurshid, Z.; Naseem, M.; Asiri, F.Y.I.; Mali, M.; Khan, R.S.; Sahibzada, H.A.; Zafar, M.S.; Moin, S.F.; Khan, E. Significance and diagnostic role of antimicrobial cathelicidins (LL-37) peptides in oral health. Biomolecules 2017, 7, 80.
  14. Khurshid, Z.; Naseem, M.; Sheikh, Z.; Najeeb, S.; Shahab, S.; Zafar, M.S. Oral antimicrobial peptides: Types and role in the oral cavity. Saudi Pharm. J. 2016, 24, 515–524.
  15. Hancock, R.E.W.; Lehrer, R. Cationic peptides: A new source of antibiotics. Trends Biotechnol. 1998, 16, 82–88.
  16. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C.; et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 1770–1773.
  17. Bals, R.; Weiner, D.J.; Moscioni, A.D.; Meegalla, R.L.; Wilson, J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 1999, 67, 6084–6089.
  18. Sarmiento, B.F.; Aminoshariae, A.; Bakkar, M.; Bonfield, T.; Ghosh, S.; Montagnese, T.A.; Mickel, A.K. The Expression of the Human Cathelicidin LL-37 in the Human Dental Pulp: An In vivo Study. Int. J. Pharm. 2016, 1, 5.
  19. Mojsoska, B.; Jenssen, H. Peptides and Peptidomimetics for Antimicrobial Drug Design. Pharmaceuticals 2015, 8, 366–415.
  20. Winfred, S.B.; Meiyazagan, G.; Panda, J.J.; Nagendrababu, V.; Deivanayagam, K.; Chauhan, V.S.; Venkatraman, G. Antimicrobial activity of cationic peptides in endodontic procedures. Eur. J. Dent. 2014, 8, 254–260.
  21. Davidopoulou, S.; Diza, E.; Menexes, G.; Kalfas, S. Salivary concentration of the antimicrobial peptide LL-37 in children. Arch. Oral Biol. 2012, 57, 865–869.
  22. Ouhara, K.; Komatsuzawa, H.; Yamada, S.; Shiba, H.; Fujiwara, T.; Ohara, M.; Sayama, K.; Hashimoto, K.; Kurihara, H.; Sugai, M. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, β-defensins and LL37, produced by human epithelial cells. J. Antimicrob. Chemother. 2005, 55, 888–896.
  23. Rechenberg, D.K.; Galicia, J.C.; Peters, O.A. Biological markers for pulpal inflammation: A systematic review. PLoS ONE 2016, 11, e0167289.
  24. Gennaro, R.; Skerlavaj, B.; Romeo, D. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Immun. 1989, 57, 3142–3146.
  25. Shaykhiev, R.; Beißwenger, C.; Kändler, K.; Senske, J.; Püchner, A.; Damm, T.; Behr, J.; Bals, R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289, L842–L848.
  26. Dürr, U.H.N.; Sudheendra, U.S.; Ramamoorthy, A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim. Biophys. Acta Biomembr. 2006, 1758, 1408–1425.
  27. Nagaoka, I.; Hirata, M.; Sugimoto, K.; Tsutsumi-Ishii, Y.; Someya, A.; Saionji, K.; Igari, J. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J. Leukoc. Biol. 1998, 64, 845–852.
  28. Seil, M.; Nagant, C.; Dehaye, J.-P.; Vandenbranden, M.; Lensink, M.F. Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties. Pharmaceuticals 2010, 3, 3435–3460.
  29. Vandamme, D.; Landuyt, B.; Luyten, W.; Schoofs, L. A Comprehensive Summary of LL-37, the Factotum Human Cathelicidin Peptide. Cell. Immunol. 2012, 280, 22–35.
  30. Duplantier, A.J.; van Hoek, M.L. The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds. Front. Immunol. 2013, 4, 143.
  31. Larrick, J.W.; Morgan, J.G.; Palings, I.; Hirata, M.; Yen, M.H. Complementary D.N.A. sequence of rabbit CAP18-A unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 1991, 179, 170–175.
  32. Clarke, J.K. On the Bacterial Factor in the Aetiology of Dental Caries. Br. J. Exp. Pathol. 1924, 5, 141–147.
  33. Hicks, J.; Garcia-Godoy, F.; Flaitz, C. Biological factors in dental caries: Role of saliva and dental plaque in the dynamic process of demineralization and remineralization (part 1). J. Clin. Pediatr. Dent. 2003, 28, 47–52.
  34. Vitorino, R.; Lobo, M.J.C.; Duarte, J.R.; Ferrer-Correia, A.J.; Domingues, P.M.; Amado, F.M.L. The role of salivary peptides in dental caries. Biomed. Chromatogr. 2005, 19, 214–222.
  35. Mizukawa, N.; Sugiyama, K.; Mishima, T.U.; Takagi, S.; Sugahara, T. Levels of human defensin-1, an antimicrobial peptide, in saliva of patients with oral inflammation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1999, 87, 539–543.
  36. Hancock, R.E.W.; Diamond, G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 2000, 8, 402–410.
  37. Bonass, W.A.; High, A.S.; Owen, P.J.; Devine, D.A. Expression of β-defensin genes by human salivary glands. Oral Microbiol. Immunol. 1999, 14, 371–374.
  38. Tao, R.; Jurevic, R.J.; Coulton, K.K.; Tsutsui, M.T.; Roberts, M.C.; Kimball, J.R.; Wells, N.; Berndt, J.; Dale, B.A. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob. Agents Chemother. 2005, 49, 3883–3888.
  39. Staquet, M.J.; Carrouel, F.; Keller, J.F.; Baudouin, C.; Msika, P.; Bleicher, F.; Kufer, T.A.; Farges, J.C. Pattern-recognition receptors in pulp defense. Adv. Dent. Res. 2011, 23, 296–301.
  40. Selders, G.S.; Fetz, A.E.; Radic, M.Z.; Bowlin, G.L. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration. Regen. Biomater. 2017, 4, 55–68.
  41. Yumoto, H.; Hirao, K.; Hosokawa, Y.; Kuramoto, H.; Takegawa, D.; Nakanishi, T.; Matsuo, T. The roles of odontoblasts in dental pulp innate immunity. Jpn. Dent. Sci. Rev. 2018, 54, 105–117.
  42. Durand, S.H.; Flacher, V.; Roméas, A.; Carrouel, F.; Colomb, E.; Vincent, C.; Magloire, H.; Couble, M.-L.; Bleicher, F.; Staquet, M.-J.; et al. Lipoteichoic Acid Increases T.L.R. and Functional Chemokine Expression while Reducing Dentin Formation in In Vitro Differentiated Human Odontoblasts. J. Immunol. 2006, 176, 2880–2887.
  43. Palosaari, H.; Wahlgren, J.; Larrnas, M.; Rönkä, H.; Sorsa, T.; Sato, T.; Tjäderhane, L. The expression of mmp-8 in human odontoblasts and dental pulp cells is down-regulated by tgf-β 1. J. Dent. Res. 2000, 79, 77–84.
  44. Arana-Chavez, V.E.; Massa, L.F. Odontoblasts: The cells forming and maintaining dentine. Int. J. Biochem. Cell Biol. 2004, 36, 1367–1373.
  45. Cekici, A.; Kantarci, A.; Hasturk, H.; Van Dyke, T.E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol. 2000 2014, 64, 57–80.
  46. Mogensen, T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22, 240–273.
  47. Horst, O.V.; Tompkins, K.A.; Coats, S.R.; Braham, P.H.; Darveau, R.P.; Dale, B.A. TGF-β1 inhibits TLR-mediated odontoblast responses to oral bacteria. J. Dent. Res. 2009, 88, 333–338.
  48. Veerayutthwilai, O.; Byers, M.R.; Pham, T.T.T.; Darveau, R.P.; Dale, B.A. Differential regulation of immune responses by odontoblasts. Oral Microbiol. Immunol. 2007, 22, 5–13.
  49. Ahlquist, M.L.; Franzen, O.G. Inflammation and dental pain in man. Dent. Traumatol. 1994, 10, 201–209.
  50. Bergenholtz, G. Inflammatory response of the dental pulp to bacterial irritation. J. Endod. 1981, 7, 100–104.
  51. Kajiya, M.; Shiba, H.; Komatsuzawa, H.; Ouhara, K.; Fujita, T.; Takeda, K.; Uchida, Y.; Mizuno, N.; Kawaguchi, H.; Kurihara, H. The antimicrobial peptide LL37 induces the migration of human pulp cells: A possible adjunct for regenerative endodontics. J. Endod. 2010, 36, 1009–1013.
  52. Odlén, K.; Fält, F.; Dahl, S.; Aidoukovitch, A.; Ericson, D.; Nilsson, B.O.; Hedenbjörk-Lager, A. Odontoblast-like MDPC-23 cells produce proinflammatory IL-6 in response to lipoteichoic acid and express the antimicrobial peptide CRAMP. Acta Odontol. Scand. 2020, 78, 210–216.
  53. Borregaard, N.; Cowland, J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997, 89, 3503–3521.
  54. Bülow, E.; Bengtsson, N.; Calafat, J.; Gullberg, U.; Olsson, I. Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells. J. Leukoc. Biol. 2002, 72, 147–153.
  55. Koczulla, R.; Von Degenfeld, G.; Kupatt, C.; Krötz, F.; Zahler, S.; Gloe, T.; Issbrücker, K.; Unterberger, P.; Zaiou, M.; Lebherz, C.; et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Investig. 2003, 111, 1665–1672.
  56. Yoshida, K.; Suzuki, S.; Kawada-Matsuo, M.; Nakanishi, J.; Hirata-Tsuchiya, S.; Komatsuzawa, H.; Yamada, S.; Shiba, H. Heparin–LL37 complexes are less cytotoxic for human dental pulp cells and have undiminished antimicrobial and LPS-neutralizing abilities. Int. Endod. J. 2019, 52, 1327–1343.
  57. Chang, W.K.; Wimley, W.C.; Searson, P.C.; Hristova, K.; Merzlyakov, M. Characterization of antimicrobial peptide activity by electrochemical impedance spectroscopy. Biochim. Biophys. Acta Biomembr. 2008, 1778, 2430–2436.
  58. Pütsep, K.; Carlsson, G.; Boman, H.G.; Andersson, M. Deficiency of antibacterial peptides in patients with morbus Kostmann: An observation study. Lancet 2002, 360, 1144–1149.
  59. Esfandiyari, R.; Halabian, R.; Behzadi, E.; Sedighian, H.; Jafari, R.; Imani Fooladi, A.A. Performance evaluation of antimicrobial peptide ll-37 and hepcidin and β-defensin-2 secreted by mesenchymal stem cells. Heliyon 2019, 5, e02652.
  60. Li, W.; Chen, L.; Chen, Z.; Wu, L.; Feng, J.; Wang, F.; Shoff, L.; Li, X.; Donly, K.J.; MacDougall, M.; et al. Dentin sialoprotein facilitates dental mesenchymal cell differentiation and dentin formation. Sci. Rep. 2017, 7, 1–18.
  61. Pober, J.S. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am. J. Pathol. 1988, 133, 426–433.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Dentistry, Oral Surgery & Medicine
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Nireeksha Shetty
View Times: 513
Entry Collection: Peptides for Health Benefits
Revisions: 2 times (View History)
Update Date: 19 May 2021
Table of Contents
    1000/1000
    Hot Most Recent
    Video Production Service
    Feedback